Opioid Withdrawal Treatment Market Research Report - Forecast till 2027

Opioid Withdrawal Treatment Market Research Report: Information by Drug Type (Nonsteroidal Anti-Inflammatory Drugs, Anti-Nausea Medications, Analgesics, Natural Sleep Supplements), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Online Stores) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6651-HCR | February 2021 | Region: Global | 90 pages

Opioid Withdrawal Treatment Market Scenario


The opioid withdrawal treatment market is expected to grow significantly over the forecast period. The market held a market value of USD 1.8 billion in 2018 and is projected to register a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain.


In some cases, usage of opioids causes addiction, and opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. The rising use of opioids for the management of pain, large healthcare expenditure, and rising chronic disorders is driving the growth of the market. 


Recent FDA approval of first non-opioid treatment for the management of opioid withdrawal symptoms in adults is propelling the opioid withdrawal treatment market.


Additionally, the rising population affected with chronic disorders, along with favorable reimbursement scenarios, is driving the growth of the market. For instance, according to the United Nations, the older population is likely to reach 425 million by 2050. Additionally, according to the World Health Organization (WHO), in 201, more than 17.7 million people died from cardiovascular diseases contributing to 31% of all the global deaths. This rise in the aging population will lead to a rise in cardiovascular disorders as this population is highly prone to various heart disorders and is at a higher risk of developing complications which are also likely to drive the market.


However, the stringent regulatory scenario is limiting the growth of the market.  


Segmentation


The opioid withdrawal treatment market has been segmented into drug type and distribution channel.


By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, analgesics, natural sleep supplements, and others.


On the basis of distribution channel, the market has been segmented into hospital pharmacy, retail pharmacies, and online stores.


The opioid withdrawal treatment market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The opioid withdrawal treatment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European opioid withdrawal treatment market has been segmented into Western Europe and Eastern Europe. Western Europe, opioid withdrawal treatment market, has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The opioid withdrawal treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Opioid withdrawal treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.


Company Profiles



  • Merck & Co.

  • Teva Pharmaceutical Industries Ltd

  • Pfizer Inc.

  • Novartis

  • Sanofi

  • Johnson & Johnson Services

  • Hoffmann-La Roche Ltd

  • Bayer AG


Regional Market Summary


Opioid Withdrawal Treatment Market Share (%), by Region, 2018  Opioid Withdrawal Treatment Market


Source: White Papers, Company Presentations, Annual Reports


The Americas is the market leader and has an attractive market for opioid withdrawal treatment owing to the increasing prevalence of chronic disorders and rising adoption of opioids for the management of pain. Additionally, the rising geriatric population is a major trigger factor that drives the opioid withdrawal treatment market. According to the Center for Disease Control and Prevention in2016, health care providers across the US wrote more than 214 million prescriptions for opioid pain medication, which is 66.5 prescriptions per 100 people.


Additionally, the CDC stated that drug overdoses claimed the lives of nearly 64,000 Americans in 2016. Nearly two-thirds of these deaths (66%) involved a prescription or illicit opioid. This overuse of opioids is driving the growth of the opioid withdrawal treatment market.


Moreover, according to the US Census Bureau, in 2016, around 49.2 million residents were aged 65 and above. This huge older population led to over 15.2% of the total population, which is likely to drive the market. Furthermore, the Americas is witnessing rampant advancements in technology, and increasing government initiatives, and funding for research in the drugs is driving the market growth.


Europe accounts for the second-largest market and holds a healthy share in the global opioid withdrawal treatment market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and rising opioid addiction. For instance, according to the European Monitoring Centre for Drugs and Drug Addiction, drug overdose deaths remain high in Europe, and opioids are implicated in the majority of cases. Moreover, according to the International Overdose Awareness Day, deaths due to the consumption of heroin and morphine doubled to 1,201 in 2015 in England and Wales. This is driving the growth of the market.


Asia-Pacific is expected to be the fastest-growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies. Moreover, due to lower cost of clinical trials, research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in opioid withdrawal treatment market in future.


The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.


Opioid Withdrawal Treatment Market, by Drug Type



  • Nonsteroidal Anti-Inflammatory Drugs

  • Anti-Nausea Medications

  • Analgesics

  • Natural Sleep Supplements

  • Others


Opioid Withdrawal Treatment Market, by Distribution Channel



  • Hospital Pharmacy

  • Retail Pharmacies

  • Online Stores


Opioid Withdrawal Treatment Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • The Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Medical device manufacturer

  • Channel partners

  • Industry association

  • Governments and investment communities

  • Research organizations and associations

  • Healthcare industry



Report Scope:
Report Attribute/Metric Details
  Market Size   2025: Significant Value
  CAGR   10.1% (2019-2025)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Drug Type, Distribution Channel
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Merck & Co., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis, Sanofi, Johnson & Johnson Services, F. Hoffmann-La Roche Ltd, and Bayer AG
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Hospital pharmacies.
  • retail pharmacies.
  • online stores


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The opioid withdrawal treatment market has the scope to record a CAGR of 10.1% during the forecast period of 2019 to 2025.

    The opioid withdrawal treatment market volume in 2018 was of USD 1.8 billion.

    The opioid withdrawal treatment market is getting backed by first time FDA approval of the non-opioid treatment.

    Hospital pharmacies, retail pharmacies, and online stores are the major end users of the opioid withdrawal treatment market.

    Different types reported for a discussion of the opioid withdrawal treatment market are anti-nausea medications, nonsteroidal anti-inflammatory drugs, natural sleep supplements, analgesics, and others.

    Table of Contents

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Detection Technique Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Opioid Withdrawal Treatment Market, by Drug Type

    6.1 Introduction

    6.2 Nonsteroidal Anti-Inflammatory Drugs

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Anti-Nausea Medications

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Analgesics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5 Natural sleep supplements

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Opioid Withdrawal Treatment Market, by Distribution Channel

    7.1 Introduction

    7.2 Hospital Pharmacy

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Retail Pharmacies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Online Stores

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Opioid Withdrawal Treatment Market, by Region

    8.1 Introduction

    8.2 Americas

    8.2.1 North America

    10.2.1.1 US

    10.2.1.2 Canada

    8.2.2 Latin America

    8.3 Europe

    8.3.1 Western Europe

    8.3.1.1 Germany

    8.3.1.2 France

    8.3.1.3 Italy

    8.3.1.4 Spain

    8.3.1.5 UK

    8.3.1.6 Rest of Western Europe

    8.3.2 Eastern Europe

    8.4 Asia-Pacific

    8.4.1 Japan

    8.4.2 China

    8.4.3 India

    8.4.4 Australia

    8.4.5 South Korea

    8.4.6 Rest of Asia-Pacific

    8.5 Middle East & Africa

    8.5.1 Middle East

    8.5.2 Africa

    Chapter 9 Company Landscape

    9.1 Introduction

    9.2 Market Share Analysis

    9.3 Key Development & Strategies

    Chapter 10. Company Profiles

    10.1 Merck & Co.

    10.1.1 Company Overview

    10.1.2 Treatment Overview

    10.1.3 Financials Overview

    10.1.4 Key Developments

    10.1.5 SWOT Analysis

    10.2 Teva Pharmaceutical Industries Ltd

    10.2.1 Company Overview

    10.2.2 Treatment Overview

    10.2.3 Financial Overview

    10.2.4 Key Developments

    10.2.5 SWOT Analysis

    10.3 Pfizer Inc.

    10.3.1 Company Overview

    10.3.2 Treatment Overview

    10.3.3 Financial Overview

    10.3.4 Key Development

    10.3.5 SWOT Analysis

    10.4 Novartis

    10.4.1 Company Overview

    10.4.2 Treatment Overview

    10.4.3 Financial Overview

    10.4.4 Key Development

    10.4.5 SWOT Analysis

    10.5 Sanofi

    10.5.1 Company Overview

    10.5.2 Treatment Overview

    10.5.3 Financial overview

    10.5.4 Key Developments

    10.5.5 SWOT Analysis

    10.6 Johnson & Johnson Services

    10.6.1 Company Overview

    10.6.2 Treatment Overview

    10.6.3 Financial Overview

    10.6.4 Key Developments

    10.6.5 SWOT Analysis

    10.7 F. Hoffmann-La Roche Ltd

    10.7.1 Company Overview

    10.7.2 Treatment Overview

    10.7.3 Financial Overview

    10.7.4 Key Developments

    10.7.5 SWOT Analysis

    10.8 Bayer AG

    10.8.1 Company Overview

    10.8.2 Treatment Overview

    10.8.3 Financials

    10.8.4 Key Developments

    10.8.5 SWOT Analysis

    Chapter 11 MRFR Conclusion

    11.1 Key Findings

    11.1.1 From CEO’s Viewpoint

    11.1.2 Unmet Needs of the Market

    11.2 Key Companies to Watch

    11.3 Predictions for the Opioid Withdrawal Treatment Industry

    Chapter 12. Appendix

    LIST OF TABLES

    Table 1 Global Opioid Withdrawal Treatment Market Synopsis, 2020-2027

    Table 2 Global Opioid Withdrawal Treatment Market Estimates and Forecast, 2020-2027

    (USD Million)

    Table 3 Global Opioid Withdrawal Treatment Market, by Region, 2020-2027(USD Million)

    Table 4 Global Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD Million)

    Table 5 Global Opioid Withdrawal Treatment Market, by Distribution Channel, 2020-2027(USD

    Million)

    Table 8 North America: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD

    Million)

    Table 9 North America: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020-2027

    (USD Million)

    Table 12 US: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD Million)

    Table 13 US: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020-2027(USD

    Million)

    Table 16 Canada: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD Million)

    Table 17 Canada: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020-2027(USD

    Million)

    Table 20 Latin America: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD

    Million)

    Table 21 Latin America: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020–

    2023 (USD Million)

    Table 24 Europe: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD Million)

    Table 25 Europe: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020-2027(USD

    Million)

    Table 28 Western Europe: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD

    Million)

    Table 29 Western Europe: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020–

    2027 (USD Million)

    Table 32 Eastern Europe: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027(USD

    Million)

    Table 33 Eastern Europe: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020–

    2027 (USD Million)

    Table 36 Asia-Pacific: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027 (USD

    Million)

    Table 37 Asia-Pacific: Opioid Withdrawal Treatment Market, by Distribution Channel, 2020-2027

    (USD Million)

    Table 40 Middle East & Africa: Opioid Withdrawal Treatment Market, by Drug Type, 2020-2027

    (USD Million)

    Table 41 Middle East & Africa: Opioid Withdrawal Treatment Market, by Distribution Channel,

    2020-2027(USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Opioid Withdrawal Treatment Market

    Figure 3 Segmentation Market Dynamics for Global Opioid Withdrawal Treatment Market

    Figure 4 Global Opioid Withdrawal Treatment Market Share, by Drug Type, 2020

    Figure 5 Global Opioid Withdrawal Treatment Market Share, by Distribution Channel, 2020

    Figure 7 Global Opioid Withdrawal Treatment Market Share, by Distribution Channel, 2020

    Figure 8 Global Opioid Withdrawal Treatment Market Share, by Region, 2020

    Figure 9 North America: Opioid Withdrawal Treatment Market Share, by Country, 2020

    Figure 10 Europe: Opioid Withdrawal Treatment Market Share, by Country, 2020

    Figure 11 Asia-Pacific: Opioid Withdrawal Treatment Market Share, by Country, 2020

    Figure 12 Middle East & Africa: Opioid Withdrawal Treatment Market Share, by Country, 201

    Figure 13 Global Opioid Withdrawal Treatment Market: Company Share Analysis, 2020 (%)

    Figure 14 Merck & Co., Inc: Key Financials

    Figure 15 Merck & Co., Inc: Segmental Revenue

    Figure 16 Merck & Co., Inc: Geographical Revenue

    Figure 17 Teva Pharmaceutical: Key Financials

    Figure 18 Teva Pharmaceutical: Segmental Revenue

    Figure 19 Teva Pharmaceutical: Geographical Revenue

    Figure 20 Novartis: Key Financials

    Figure 21 Novartis: Segmental Revenue

    Figure 22 Novartis: Geographical Revenue

    Figure 23 Sanofi: Key Financials

    Figure 24 Sanofi: Segmental Revenue

    Figure 25 Sanofi.: Geographical Revenue




    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.